Top pick for
All rounder
How to buy Genus shares | 3518p
Own Genus shares in just a few minutes.
Fact checked
Genus plc (GNS) is a leading biotechnology business based in the UK. It opened the day at 3592p after a previous close of 3522p. During the day the price has varied from a low of 3482p to a high of 3592p. The latest price was 3518p (25 minute delay). Genus is listed on the London Stock Exchange (LSE) and employs 3,000 staff. All prices are listed in pence sterling.
How to buy shares in Genus
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: GNS in this case.
- Research Genus shares. The platform should provide the latest information available.
- Buy your Genus shares. It's that simple.
How has Coronavirus impacted Genus's share price?
Since the stock market crash in March caused by coronavirus, Genus's share price has had significant positive movement.
Its last market close was 3532p, which is 6.74% up on its pre-crash value of 3294p and 43.31% up on the lowest point reached during the March crash when the shares fell as low as 2464.6p.
If you had bought £1,000 worth of Genus shares at the start of February 2020, those shares would have been worth £927.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,146.84.
Genus share price
Use our graph to track the performance of GNS stocks over time.Genus shares at a glance
Information last updated 2020-07-02.
| Open | 3592p |
|---|---|
| High | 3592p |
| Low | 3482p |
| Close | 3518p |
| Previous close | 3522p |
| Change | -4p |
| Change % | -0.114% |
| Volume | 61,567 |
Information last updated 2020-07-12.
| 52-week range | 2460p - 3760p |
|---|---|
| 50-day moving average | 3411.1177p |
| 200-day moving average | 3277.9858p |
| Wall St. target price | 2332.5p |
| PE ratio | 58.9649 |
| Dividend yield | 0.28p (0.82%) |
| Earnings per share (TTM) | 57.6p |
Get your first 50 trades commission free with Fineco
Fees apply. Your capital is at risk.
- Market leading platform
- No minimum deposit, no conversion fee, no monthly fee
- Your first 50 share trades are free until 30/09/2020
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.
Is it a good time to buy Genus stock?
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Genus price performance over time
Historical closes compared with the last close of 3518p
| 1 week (2020-07-06) | 0.23% |
|---|---|
| 1 month (2020-06-12) | 8.38% |
| 3 months (2020-04-09) | 5.20% |
| 6 months (2020-01-13) | 13.34% |
| 1 year (2019-07-12) | 34.58% |
|---|---|
| 2 years (2018-07-13) | 24.49% |
| 3 years (2017-07-13) | 103.47% |
| 5 years (2015-07-13) | 139.32% |
Is Genus under- or over-valued?
Valuing Genus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genus's P/E ratio
Genus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 59x. In other words, Genus shares trade at around 59x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Genus's EBITDA
Genus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £39.4 million.
The EBITDA is a measure of a Genus's overall financial performance and is widely used to measure a its profitability.
Genus financials
| Revenue TTM | £520.4 million |
|---|---|
| Operating margin TTM | 3.34% |
| Gross profit TTM | £186 million |
| Return on assets TTM | 1.33% |
| Return on equity TTM | 7.71% |
| Profit margin | 7.44% |
| Book value | 7.646p |
| Market capitalisation | £2.2 billion |
TTM: trailing 12 months
Genus share dividends
Dividend payout ratio: 46.24% of net profits
Recently Genus has paid out, on average, around 46.24% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genus shareholders could enjoy a 0.82% return on their shares, in the form of dividend payments. In Genus's case, that would currently equate to about 0.28p per share.
While Genus's payout ratio might seem fairly standard, it's worth remembering that Genus may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 March 2020 (the "ex-dividend date").
Genus share price volatility
Over the last 12 months, Genus's shares have ranged in value from as little as 2460p up to 3760p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Genus's is 0.3901. This would suggest that Genus's shares are less volatile than average (for this exchange).
Genus overview
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates in three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers. The company has a strategic porcine collaboration with Beijing Capital Agribusiness Co. Ltd to research, develop, register, and market porcine reproductive and respiratory syndrome virus resistant pigs. Genus plc was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Frequently asked questions
Ask an Expert